The study confirms that prebiotic ingredient Bimuno GOS exerts a proven prebiotic effect at ultra-low doses from just 380 mg of active GOS per day
Vidya proudly announces the successful completion of a human clinical trial with NūGensia at a 5 billion CFU dose — the first human study of its kind with live Akkermansia...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.